These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36063051)

  • 21. Clustered Regularly Interspaced Short Palindromic Repeats System of Genome Engineering in Embryos to Repair Genes.
    Niazvand F; Fathinezhad Z; Alfuraiji N; Etajuri EA; Amini-Chermahini F; Chehelgerdi M; Ranjbar R
    J Biomed Nanotechnol; 2021 Mar; 17(3):331-356. PubMed ID: 33875070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CRISPR Platform for Targeted In Vivo Screens.
    Maranda V; Zhang Y; Vizeacoumar FS; Freywald A; Vizeacoumar FJ
    Methods Mol Biol; 2023; 2614():397-409. PubMed ID: 36587138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution characterization of gene function using single-cell CRISPR tiling screen.
    Yang L; Chan AKN; Miyashita K; Delaney CD; Wang X; Li H; Pokharel SP; Li S; Li M; Xu X; Lu W; Liu Q; Mattson N; Chen KY; Wang J; Yuan YC; Horne D; Rosen ST; Soto-Feliciano Y; Feng Z; Hoshii T; Xiao G; Müschen M; Chen J; Armstrong SA; Chen CW
    Nat Commun; 2021 Jul; 12(1):4063. PubMed ID: 34210975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.
    Song X; Liu C; Wang N; Huang H; He S; Gong C; Wei Y
    Adv Drug Deliv Rev; 2021 Jan; 168():158-180. PubMed ID: 32360576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
    Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
    Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editing
    Dehshahri A; Biagioni A; Bayat H; Lee EHC; Hashemabadi M; Fekri HS; Zarrabi A; Mohammadinejad R; Kumar AP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets.
    Noorani I; Bradley A; de la Rosa J
    Genome Biol; 2020 Aug; 21(1):204. PubMed ID: 32811551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide pooled CRISPR screening in neurospheres.
    Abid T; Goodale AB; Kalani Z; Wyatt M; Gonzalez EM; Zhou KN; Qian K; Novikov D; Condurat AL; Bandopadhayay P; Piccioni F; Persky NS; Root DE
    Nat Protoc; 2023 Jul; 18(7):2014-2031. PubMed ID: 37286821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic screens: CRISPR-based mapping of genetic interactions.
    Cloney R
    Nat Rev Genet; 2017 May; 18(5):272-273. PubMed ID: 28366937
    [No Abstract]   [Full Text] [Related]  

  • 31. Advances in biosensing: The CRISPR/Cas system as a new powerful tool for the detection of nucleic acids.
    Bonini A; Poma N; Vivaldi F; Kirchhain A; Salvo P; Bottai D; Tavanti A; Di Francesco F
    J Pharm Biomed Anal; 2021 Jan; 192():113645. PubMed ID: 33039910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
    Potts MA; McDonald JA; Sutherland KD; Herold MJ
    Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research Techniques Made Simple: CRISPR Genetic Screens.
    Otten ABC; Sun BK
    J Invest Dermatol; 2020 Apr; 140(4):723-728.e1. PubMed ID: 32200874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
    Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
    mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the CRISPR-Associated Genes by Rv2837c (CnpB) via an Orn-Like Activity in Tuberculosis Complex Mycobacteria.
    Zhang Y; Yang J; Bai G
    J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges.
    Cheng X; Fan S; Wen C; Du X
    Brief Funct Genomics; 2020 May; 19(3):209-214. PubMed ID: 32052006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclease-Deficient Clustered Regularly Interspaced Short Palindromic Repeat-Based Approaches for
    Lek A; Ma K; Woodman KG; Lek M
    Hum Gene Ther; 2021 Mar; 32(5-6):260-274. PubMed ID: 33446040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elucidating drug targets and mechanisms of action by genetic screens in mammalian cells.
    Kampmann M
    Chem Commun (Camb); 2017 Jun; 53(53):7162-7167. PubMed ID: 28487920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics.
    Hart T; Brown KR; Sircoulomb F; Rottapel R; Moffat J
    Mol Syst Biol; 2014 Jul; 10(7):733. PubMed ID: 24987113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.